vs
Side-by-side financial comparison of ConocoPhillips (COP) and Stryker Corporation (SYK). Click either name above to swap in a different company.
ConocoPhillips is the larger business by last-quarter revenue ($11.4B vs $7.2B, roughly 1.6× Stryker Corporation). ConocoPhillips runs the higher net margin — 12.7% vs 11.8%, a 0.8% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs -10.7%). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs -3.8%).
ConocoPhillips Company is an American multinational corporation engaged in hydrocarbon exploration and production. It is based in the Energy Corridor district of Houston, Texas.
The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).
COP vs SYK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.4B | $7.2B |
| Net Profit | $1.4B | $849.0M |
| Gross Margin | 54.4% | 64.5% |
| Operating Margin | 19.7% | 25.2% |
| Net Margin | 12.7% | 11.8% |
| Revenue YoY | -10.7% | 11.4% |
| Net Profit YoY | -37.5% | 55.5% |
| EPS (diluted) | $1.18 | $2.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.4B | $7.2B | ||
| Q3 25 | $13.3B | $6.1B | ||
| Q2 25 | $12.6B | $6.0B | ||
| Q1 25 | $14.5B | $5.9B | ||
| Q4 24 | $12.7B | $6.4B | ||
| Q3 24 | $11.7B | $5.5B | ||
| Q2 24 | $12.7B | $5.4B | ||
| Q1 24 | $12.3B | $5.2B |
| Q4 25 | $1.4B | $849.0M | ||
| Q3 25 | $1.7B | $859.0M | ||
| Q2 25 | $2.0B | $884.0M | ||
| Q1 25 | $2.8B | $654.0M | ||
| Q4 24 | $2.3B | $546.0M | ||
| Q3 24 | $2.1B | $834.0M | ||
| Q2 24 | $2.3B | $825.0M | ||
| Q1 24 | $2.6B | $788.0M |
| Q4 25 | 54.4% | 64.5% | ||
| Q3 25 | 56.1% | 63.6% | ||
| Q2 25 | 59.7% | 63.8% | ||
| Q1 25 | 57.3% | 63.8% | ||
| Q4 24 | 60.2% | 64.9% | ||
| Q3 24 | 59.4% | 64.0% | ||
| Q2 24 | 61.6% | 63.0% | ||
| Q1 24 | 56.7% | 63.6% |
| Q4 25 | 19.7% | 25.2% | ||
| Q3 25 | 22.0% | 18.7% | ||
| Q2 25 | 23.9% | 18.5% | ||
| Q1 25 | 30.8% | 14.3% | ||
| Q4 24 | 23.3% | 9.0% | ||
| Q3 24 | 27.6% | 19.7% | ||
| Q2 24 | 28.9% | 19.4% | ||
| Q1 24 | 30.9% | 18.5% |
| Q4 25 | 12.7% | 11.8% | ||
| Q3 25 | 12.9% | 14.2% | ||
| Q2 25 | 15.6% | 14.7% | ||
| Q1 25 | 19.7% | 11.1% | ||
| Q4 24 | 18.1% | 8.5% | ||
| Q3 24 | 17.6% | 15.2% | ||
| Q2 24 | 18.4% | 15.2% | ||
| Q1 24 | 20.7% | 15.0% |
| Q4 25 | $1.18 | $2.20 | ||
| Q3 25 | $1.38 | $2.22 | ||
| Q2 25 | $1.56 | $2.29 | ||
| Q1 25 | $2.23 | $1.69 | ||
| Q4 24 | $1.92 | $1.41 | ||
| Q3 24 | $1.76 | $2.16 | ||
| Q2 24 | $1.98 | $2.14 | ||
| Q1 24 | $2.15 | $2.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.0B | $4.0B |
| Total DebtLower is stronger | $22.4B | — |
| Stockholders' EquityBook value | $64.5B | $22.4B |
| Total Assets | $121.9B | $47.8B |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.0B | $4.0B | ||
| Q3 25 | $6.3B | $3.3B | ||
| Q2 25 | $5.3B | $2.4B | ||
| Q1 25 | $7.2B | $2.3B | ||
| Q4 24 | $6.1B | $3.7B | ||
| Q3 24 | $6.8B | $3.9B | ||
| Q2 24 | $6.0B | $1.9B | ||
| Q1 24 | $6.1B | $2.3B |
| Q4 25 | $22.4B | — | ||
| Q3 25 | $22.5B | — | ||
| Q2 25 | $23.1B | — | ||
| Q1 25 | $23.2B | — | ||
| Q4 24 | $23.3B | — | ||
| Q3 24 | $17.0B | — | ||
| Q2 24 | $17.0B | — | ||
| Q1 24 | $17.3B | — |
| Q4 25 | $64.5B | $22.4B | ||
| Q3 25 | $64.9B | $21.8B | ||
| Q2 25 | $65.6B | $21.2B | ||
| Q1 25 | $65.2B | $20.9B | ||
| Q4 24 | $64.8B | $20.6B | ||
| Q3 24 | $49.9B | $20.1B | ||
| Q2 24 | $49.7B | $19.8B | ||
| Q1 24 | $49.3B | $19.2B |
| Q4 25 | $121.9B | $47.8B | ||
| Q3 25 | $122.5B | $47.1B | ||
| Q2 25 | $122.6B | $46.3B | ||
| Q1 25 | $124.3B | $46.0B | ||
| Q4 24 | $122.8B | $43.0B | ||
| Q3 24 | $96.7B | $43.8B | ||
| Q2 24 | $96.0B | $39.1B | ||
| Q1 24 | $95.3B | $39.4B |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.36× | — | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.3B | $2.1B |
| Free Cash FlowOCF − Capex | — | $1.9B |
| FCF MarginFCF / Revenue | — | 26.1% |
| Capex IntensityCapex / Revenue | — | 3.7% |
| Cash ConversionOCF / Net Profit | 2.99× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.3B | $2.1B | ||
| Q3 25 | $5.9B | $1.5B | ||
| Q2 25 | $3.5B | $1.1B | ||
| Q1 25 | $6.1B | $250.0M | ||
| Q4 24 | $4.5B | $1.9B | ||
| Q3 24 | $5.8B | $1.5B | ||
| Q2 24 | $4.9B | $633.0M | ||
| Q1 24 | $5.0B | $204.0M |
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $928.0M | ||
| Q1 25 | — | $127.0M | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $481.0M | ||
| Q1 24 | — | $37.0M |
| Q4 25 | — | 26.1% | ||
| Q3 25 | — | 22.3% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 25.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | — | 3.7% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 3.1% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 2.99× | 2.52× | ||
| Q3 25 | 3.41× | 1.79× | ||
| Q2 25 | 1.77× | 1.26× | ||
| Q1 25 | 2.15× | 0.38× | ||
| Q4 24 | 1.93× | 3.54× | ||
| Q3 24 | 2.80× | 1.77× | ||
| Q2 24 | 2.11× | 0.77× | ||
| Q1 24 | 1.95× | 0.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COP
| Natural Gas Reserves | $2.1B | 18% |
| Physical Gas Contracts | $2.0B | 18% |
| Europe Middle East And North Africa Segment | $1.6B | 14% |
| Natural Gas Product Line | $1.5B | 13% |
| Canada Operating Segment | $1.3B | 12% |
| Alaska Segment | $1.3B | 11% |
| Natural Gas Liquids Reserves | $826.0M | 7% |
| Asia Pacific Operating Segment | $360.0M | 3% |
| Crude Oil Product Line | $236.0M | 2% |
| Related Party | $12.0M | 0% |
| Corporate Segment | $7.0M | 0% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
